Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001475030-17-000002
Filing Date
2017-07-24
Accepted
2017-07-24 15:38:32
Documents
1
Effectiveness Date
2017-07-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9154
  Complete submission text file 0001475030-17-000002.txt   10165
Mailing Address 8 PENN CENTER PHILADELPHIA PA 19103
Business Address 8 PENN CENTER PHILADELPHIA PA 19103 267-273-7940
Tarsa Therapeutics, Inc. (Filer) CIK: 0001475030 (see all company filings)

EIN.: 264828302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-291370 | Film No.: 17978284